6th Microbiome Movement - Drug Development Summit Europe

Kongressthemen
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

Kongressorganizer (PCO)
Hanson Wade

https://go.evvnt.com/919896-2?pid=4832

Frau Emily Lincoln